Search

everythinglearnresearchcommunity

for

Search:↓

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Taking too much Albendazole can cause hair loss and other serious side effects.

Taking too much Albendazole can cause hair loss and other serious side effects.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

PRP treatment can improve hair density and thickness in male pattern hair loss, but better preparation methods are needed.

PRP can help treat hair loss but needs standardized methods for best results.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

To prevent thinning in the donor area, harvest less than 50% of the original hair density in repeat hair transplants.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

The document concludes that terbinafine is effective for treating scalp fungal infections in children and recommends not excluding them from school during treatment, while also highlighting the need for updated treatment guidelines due to changing infection patterns.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

COVID-19 infection can significantly cause temporary hair loss.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Early diagnosis and a combination of treatments, including minoxidil and finasteride, are recommended for managing hair loss in India.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

SCD1 is important for hair growth by keeping the connection in skin cells where hair stem cells live stable.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Scientists turned mouse skin cells into hair-inducing cells using chemicals, which could help treat hair loss.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

New method improves copper peptide delivery for hair growth three times better than current options.